Cluster identity (Total number of genes) [Number of genes with differential display: Up-regulated/Down-regulated] | |
---|---|
Enriched category (p-value) | Gene symbols of major candidate genes (Vector of differential) |
Cluster 1, K1 (3210) [208: 120/88] | |
Cell cycle (<0.01) | CCNB1, CDC45L, CENPF, NCAPD3, RAD51 (up); |
 | CCND2, MYL9, ORC6L, TNPO1 (down) |
IGF-1 receptor signalling (<0.01) | IGF2 (up), IGFBP5, CCND2 (down) |
Cytoskeleton remodelling involving regulation of actin (<0.02) | MYH9, MYL9 (down) |
O-glycan biosynthesis (<0.02) | GALNT1, GALNT7 (down) |
Immune response(<0.02) | PGR (up), CCND2 (down) |
G-protein signalling in TC21 regulation pathway (<0.02) | RRAS2 (up), RASGRP2 (down) |
DNA damage (<0.03) | NBN, RAD51 (up), CCND2 (down) |
Neurite outgrowth (<0.05) | MYH9, MYL9 (down) |
Regulation of glucose and lipid metabolism (<0.05) | CYP51A1, FOXA (up), TNPO1 (down) |
G-protein signalling in Rap1 regulation pathway (<0.05) | KRIT1 (up), RASGRP2 (down) |
Progesterone action (<0.05) | CCNB1, PGR (up) |
Signal transduction: | Â |
Erk interactions (<0.04) | DUSP4 (up) |
AKT signaling (<0.05) | HSP90AA1 (up), CCDD2 (down) |
Cluster 2, K2 (8194) [148: 0/148] | |
Immune response (0) | ACTG1, C3, C4B, C1QB, HLA-C, PTPN11/SHP2 (down) |
Cell adhesion (0) | ACTG1, ITGB1, PTPN11/SHP2 (down) |
Regulation of CFTR (0) | ACTG1, HSPA8, PSMB1, TSG101, UBC (down) |
Signal transduction involving activin A signalling regulation (0) | BAMBI, H3F3A, UBC (down) |
Slit-Robo signaling (<0.01) | ACTG1, ROBO3 (down) |
Cytoskeletal remodelling (<0.01) | ACTG1, DSTN, RALGDS (down) |
Glutathione metabolism (<0.01) | GSTM5, MGST3 (down) |
Chemotaxis (<0.02) | ACTG1, GNG4, ITGB1 (down) |
Apoptosis and survival (<0.02) | HSPA8, ACTG1 (down) |
Glucose and lipid metabolism (<0.03) | APOE (down) |
Neurite outgrowth (<0.03) | ACTG1, DSTN (down) |
N-glycan biosynthesis (<0.04) | GALT, GANAB (down) |
Cluster 3, K3 (6078) [102: 102/0] | |
Differentiation (0) | PRKCG (up) |
Transcriptional regulation of amino acid metabolism (0) | MAX, PRKCG (up) |
Androgen receptor nuclear signaling (<0.01) | NCOA2/GRIP1, WNT16 (up) |
Neurophysiological process associated with PGE2-induced pain processing (<0.01) | GLRA3 (up) |